SESSION 9. AUTHORITIES REVIEW OF PV DATA FROM CLINICAL DEVELOPMENT TO WHEN THINGS GO WRONG

From Signal to Action: How Authorities Respond to Safety Issues in Clinical Trials
November, Thursday 20 | 09:35 - 09:55

Speakers

ELENA PROKOFYEVA
FAMHP - Coordinator of Drug Safety Unit